Av. Alesenko et al., CHANGES IN SPHINGOSINE LEVEL IN RAT-LIVER CELLS AND NUCLEI DURING CYCLOHEXIMIDE-INDUCED HYPEREXPRESSION OF ONCOGENES, Biochemistry, 59(7), 1994, pp. 807-814
The dependence of sphingosine content on the level of nuclear oncogene
expression induced by various doses of cycloheximide (0.1, 0.5, and 3
.0 mg/kg) was analyzed in rat liver cells and nuclei. Only sublethal d
oses (3.0 mg/kg), which cause hyperexpression of c-fos and c-myc oncog
enes, lead to accumulation of sphingosine in the cells. With enhanced
expression of these nuclear oncogenes, the maximum content of free sph
ingosine exceeds the control 1.5- and 3-fold in whole cells and nuclei
, respectively. These values suggest more intensive sphingosine metabo
lism in the nuclei. Accumulation of sphingosine in the nuclei depends
on the sphingomyelinase activity and sphingomyelin content. The activi
ty of sphingomyelinase, an enzyme of the sphingomyelin cycle, and that
of phosphatidylinositol kinase, an enzyme of the phosphoinositides cy
cle, were compared. In the nucleus the former is activated before the
latter and before the maximum accumulation of cycloheximide-induced nu
clear oncogene mRNAs. It is suggested that activation of oncogene expr
ession is mediated by sphingosine-induced inhibition of protein kinase
C and activation of casein kinase II, key enzymes of cell proliferati
on and differentiation signaling.